Edgewise Therapeutics to Present on Sevasemten for Becker and Duchenne Muscular Dystrophies at the 30th International Annual Congress of the World Muscle Society
Edgewise Therapeutics(US:EWTX) Prnewswire·2025-10-02 20:00Details of the Edgewise symposium and scientific posters at WMS: Edgewise Symposium with Key Opinion Leaders Date:Â Wednesday, October 8, 2025, at 7 pm CET Title:Â Breakthroughs in Becker: Unveiling New Natural History Insights and a Novel Agent's Clinical Progress Accessibility StatementSkip Navigation BOULDER, Colo., Oct. 2, 2025 /PRNewswire/ --Â Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced its participation at the 30th International Annu ...